166 studies found for:    Open Studies | "Anemia, Sickle Cell"
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Condition: Anemia, Sickle Cell
Interventions: Drug: Rivipansel;   Other: Placebo
2 Recruiting Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease
Condition: Anemia, Sickle Cell
Intervention: Behavioral: Cogmed RM
3 Not yet recruiting A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients
Condition: Anemia, Sickle Cell
Interventions: Drug: SANGUINATE 320 mg/kg;   Drug: Normal Saline
4 Recruiting Study of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive Crisis
Condition: Anemia, Sickle Cell
Interventions: Drug: SANGUINATE;   Drug: Placebo
5 Not yet recruiting PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: L-citrulline tablets, 1000 mg
6 Recruiting Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition: Sickle Cell Disease
Intervention: Other: SCD Group
7 Recruiting SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge
Condition: Sickle Cell Disease
Intervention: Device: SMART app
8 Not yet recruiting Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease
Condition: Sickle Cell Disease
Intervention: Other: telephone interview
9 Recruiting Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Sickle Cell Anemia and Other Blood Disorders
Condition: Sickle Cell Disease
Interventions: Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Drug: Sirolimus;   Procedure: Allogeneic bone marrow transplantation;   Radiation: total-body irradiation;   Drug: Levetiracetam
10 Recruiting Cardiovascular Complications of Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Procedure: MRI, Transthoracic Echocardiography, tonometry, EKG
11 Recruiting Transfusion Alternatives Pre-Operatively in Sickle Cell Disease (TAPS)
Condition: Sickle Cell Disease
Intervention: Other: Red cell blood transfusion
12 Recruiting Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: CD34 selected T-cell depleted allogeneic SCT
13 Recruiting ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Behavioral: Mobile DOT
14 Recruiting Screening Patients With Sickle Cell Disease for Kidney Damage
Condition: Sickle Cell Disease
Intervention:
15 Recruiting Oxygen Therapy and Pregnancy in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Device: oxygen therapy
16 Not yet recruiting Omega-3 Fatty Acids in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: SCD-Omegatex™
17 Recruiting Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.
Condition: Sickle Cell Disease
Intervention: Other: Survey
18 Recruiting Stem Cell Gene Therapy for Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Genetic: βAS3-FB vector transduced BM CD34+ cells
19 Recruiting The Role of Endothelin-1 in Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Drug: Ambrisentan;   Drug: Placebo
20 Recruiting Cerebrovascular Reserve Measurements in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Acetazolamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.